(KV) KALIVIR IMMUNOTHERAPEUTICS Trademark

Trademark Overview


On Wednesday, December 1, 2021, a trademark application was filed for (KV) KALIVIR IMMUNOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the (KV) KALIVIR IMMUNOTHERAPEUTICS trademark a serial number of 97150675. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, December 24, 2024. This trademark is owned by KALIVIR IMMUNOTHERAPEUTICS, INC.. The (KV) KALIVIR IMMUNOTHERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith
(kv) kalivir immunotherapeutics

General Information


Serial Number97150675
Word Mark(KV) KALIVIR IMMUNOTHERAPEUTICS
Filing DateWednesday, December 1, 2021
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, December 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Description of MarkThe mark consists of the letters "KV" in black between two parentheses in black with a red slash across the letters "KV," all placed next to the words "KALIVIR IMMUNOTHERAPEUTICS" in black with the second "I" in "KALIVIR" being red.
Goods and ServicesBiological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith
Indication of Colors claimedThe color(s) red and black is/are claimed as a feature of the mark.
NOT AVAILABLE"IMMUNOTHERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKALIVIR IMMUNOTHERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15238

Party NameKALIVIR IMMUNOTHERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15238

Trademark Events


Event DateEvent Description
Saturday, December 4, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Monday, September 19, 2022NON-FINAL ACTION WRITTEN
Monday, September 19, 2022NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 27, 2023FINAL REFUSAL WRITTEN
Thursday, April 27, 2023FINAL REFUSAL E-MAILED
Thursday, April 27, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 21, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 21, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, October 25, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 25, 2023EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, October 25, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, October 25, 2023EX PARTE APPEAL-INSTITUTED
Thursday, January 4, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, October 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 2, 2024EXPARTE APPEAL TERMINATED
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT